| Device Classification Name |
Enzyme Immunoassay, Opiates
|
| 510(k) Number |
K221605 |
| Device Name |
Emit® II Plus Buprenorphine Assay |
| Applicant |
| Siemens Healthcare Diagnostics, Inc. |
| 500 Gbc Dr., P.O. Box 6101 |
| Mail Stop 514 |
|
Newark,
DE
19714
|
|
| Applicant Contact |
Julie Warren |
| Correspondent |
| Siemens Healthcare Diagnostics, Inc. |
| 500 Gbc Dr., P.O. Box 6101 |
| Mail Stop 514 |
|
Newark,
DE
19714
|
|
| Correspondent Contact |
Julie Warren |
| Regulation Number | 862.3650 |
| Classification Product Code |
|
| Subsequent Product Code |
|
| Date Received | 06/02/2022 |
| Decision Date | 07/25/2023 |
| Decision |
Substantially Equivalent
(SESE) |
| Regulation Medical Specialty |
Toxicology
|
| 510k Review Panel |
Toxicology
|
| Summary |
Summary
|
| FDA Review |
Decision Summary
|
| Type |
Traditional
|
| Reviewed by Third Party |
No
|
| Combination Product |
No
|
Predetermined Change Control Plan Authorized |
No
|
|
|